Glass House Brands moves to NYSE and ships CBD hemp material to Europe
The California cannabis cultivator's third-quarter filing records a new US listing venue, a narrower reporting structure and a first European CBD shipment, but the excerpt carries no financial results.
Glass House Brands has changed where its stock trades, how it reports and where it sells. Its management's discussion and analysis for the three and nine months to 30 September 2026, dated 16 November, records all three changes. The excerpt reviewed contains no revenue, margin or earnings figures, so the commercial impact is not yet measurable.
Subscribe to keep reading
$4.99 / month
- Every article, analysis and opinion piece on CompePharma and VigiEye
- One subscription for both sites, cancel any time
Already a subscriber? Enter your email below: we'll send you a sign-in link. No password needed.
Company's press release (SEC filing): Glass House Brands Inc. ↗
Written by CompePharma's editorial system from the company's filing; claims are the company's. AI-assisted; check the source before acting. Not investment advice.